RAFAEL HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
RAFAEL HOLDINGS, INC. (RFL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.74 million shares for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-04-30 was 2.74M shares, a 1.53% increase year-over-year.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-01-31 was 2.78M shares, a 113.23% increase year-over-year.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-10-31 was 3.19M shares, a 185.66% increase year-over-year.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-04-30 was 2.70M shares, a 103.71% increase year-over-year.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.75M shares, a 200.45% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.25M shares, a 16.19% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.07M shares.
- RAFAEL HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 626.66K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-04-30 | 2.74M shares 10-Q · filed 2026-06-11 | 2.74M shares 10-Q · filed 2026-06-11 | |||||
| 2026-01-31 | 2.78M shares 10-Q · filed 2026-03-16 | 2.78M shares 10-Q · filed 2026-03-16 | |||||
| 2025-10-31 | 3.19M shares 10-Q · filed 2025-12-12 | ||||||
| 2025-07-31 | 3.75M shares 10-K · filed 2025-10-29 | ||||||
| 2025-04-30 | 2.70M shares 10-Q · filed 2026-06-11 | 2.70M shares 10-Q · filed 2026-06-11 | |||||
| 2025-01-31 | 1.30M shares 10-Q · filed 2026-03-16 | 883.25K shares 10-Q · filed 2025-03-14 | 1.30M shares 10-Q · filed 2026-03-16 | ||||
| 2024-10-31 | 1.12M shares 10-Q · filed 2025-12-12 | ||||||
| 2024-07-31 | 1.25M shares 10-K · filed 2025-10-29 | ||||||
| 2024-04-30 | 1.32M shares 10-Q · filed 2025-06-11 | 1.32M shares 10-Q · filed 2025-06-11 | 1.31M shares 10-Q · filed 2024-06-14 | ||||
| 2024-01-31 | 638.41K shares 10-Q · filed 2025-03-14 | 638.41K shares 10-Q · filed 2025-03-14 | |||||
| 2023-10-31 | 1.24M shares 10-Q · filed 2024-12-11 | ||||||
| 2023-07-31 | 1.07M shares 10-K/A · filed 2024-12-20 | ||||||
| 2023-04-30 | 1.32M shares 10-Q · filed 2024-06-14 | 1.31M shares 10-Q · filed 2024-06-14 | |||||
| 2023-01-31 | 1.95M shares 10-Q · filed 2024-03-14 | 1.95M shares 10-Q · filed 2024-03-14 | |||||
| 2022-10-31 | 2.48M shares 10-Q · filed 2023-12-14 | ||||||
| 2021-04-30 | 26.19K shares 10-Q · filed 2021-06-14 | 26.19K shares 10-Q · filed 2021-06-14 | |||||
| 2020-04-30 | 580.87K shares 10-Q · filed 2020-06-09 | ||||||
| 2020-01-31 | 586.87K shares 10-Q · filed 2020-03-05 | ||||||
| 2019-10-31 | 586.87K shares 10-Q · filed 2019-12-09 | ||||||
| 2019-07-31 | 2.43M shares 10-Q · filed 2019-12-09 | 2.43M shares 10-Q · filed 2020-03-05 | 2.43M shares 10-Q · filed 2020-06-09 | ||||
| 2019-04-30 | 573.13K shares 10-Q · filed 2019-06-05 | ||||||
| 2018-07-31 | 626.66K shares 10-K · filed 2019-10-04 | 626.58K shares 10-Q · filed 2019-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |